JPRN-jRCT2080224849终止2 期
Please refer to ClinicalTrials.gov : NCT03954041
适应症
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 85age old（—）
- 性别
- All
入选标准
- •Please refer to ClinicalTrials.gov : NCT03954041
排除标准
- •Please refer to ClinicalTrials.gov : NCT03954041
研究者
相似试验
终止
3 期
Please refer to ClinicalTrials.gov : NCT02864953.JPRN-jRCT2080224029Biogen Japan Ltd.768
已完成
3 期
Please refer to ClinicalTrials.gov : NCT03070119.amyotrophic lateral sclerosis (ALS) with a confirmed mutation in the human superoxide dismutase 1 (SOD1) geneJPRN-jRCT2080225019Biogen Japan Ltd.138
已完成
3 期
Please refer to ClinicalTrials.gov : NCT04241068.Alzheimer's diseaseJPRN-jRCT2080225185Biogen Japan Ltd.2,400
招募中
2 期
Effectiveness of Perilla oil with Mild to Moderate of Dementia PatientDevelopment of the medical and society led to population in the world are long life which rate of height birth in last time relate with be in move to aged elderly. Campaign for control the birth rateDementia,alzheimer's disease,Perilla frutescens (L.) Britton,Omaga3,Clinical Trial,Randomize Control Trial,Cognitive function,MOCATCTR20150914001Agricultural Research Development Agency (Public Organization)234
已完成
不适用
Attribution of non-ClinicalTrials.gov registries among World Health Organization International Clinical Trials Registry Platform-registered trials from 2014 to 2018: a meta-epidemiological studyregistered trials on World Health Organization International Clinical Trials Registry Platform (ICTRP)JPRN-UMIN000034401Department of Psychiatry, Seichiryo Hospital